Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D02011 (
FAD
)
5,530
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
E. coli
Dihydropteridine reductase
, known to have a pterin-independent oxidoreductase activity with potassium ferricyanide as electron donor, has now been shown to possess also dihydrofolate reductase activity. The kinetic parameters for dihydrofolate reductase activity have been determined. The ratio of the three activities,
dihydropteridine reductase
, dihydrofolate reductase and pterin-independent oxidoreductase activity is 1.0, 0.05 and 4.3, respectively. The enzyme, a flavoprotein which is unstable in the presence of dithiothreitol, was shown to be a monomer with a molecular mass of 25.7 kDa. The apparent lack of discrimination between hydride transfer from the pyridine nucleotide to N5 of the pterin in the
dihydropteridine reductase
reaction and C6 of folate in the dihydrofolate reaction suggested that the
FAD
prosthetic group may be involved in the hydride transfers. The flavoprotein inhibitor N,N- dimethylpropargylamine inhibited the
dihydropteridine reductase
and oxidoreductase reactions differently and did not affect the dihydrofolate reductase activity however.
...
PMID:Dihydropteridine reductase from Escherichia coli exhibits dihydrofolate reductase activity. 141 77
A
dihydropteridine reductase
from Escherichia coli was purified to apparent homogeneity. It is a dimeric enzyme with identical subunits (Mr 27000) and a free N-terminal group. It can use NADH (Vmax./Km 3.36 s-1) and NADPH (Vmax./Km 1.07 s-1) when 6-methyldihydro-(6H)-pterin is the second substrate, as well as quinonoid dihydro-(6H)-biopterin (Vmax./Km 0.69 s-1), dihydro-(6H)-neopterin (Vmax./Km 0.58 s-1), dihydro-(6H)-monapterin 0.66 s-1), 6-methyldihydro-(6H)-pterin and cis-6,7-dimethyldihydro-(6H)-pterin (Vmax./Km 0.66 s-1) when NADH is the second substrate. The pure reductase has a yellow colour and contains bound
FAD
. The enzyme also has pterin-independent NADH and NADPH oxidoreductase activities when potassium ferricyanide is the electron acceptor.
...
PMID:Dihydropteridine reductase from Escherichia coli. 306 Jan 13
The nitric oxide synthases (NOS) are a class of enzymes responsible for the generation of NO via an oxygen and NADPH dependent oxidation of the amino acid arginine. These enzymes are ironheme proteins which contain
FAD
and FMN and, enigmatically, require tetrahydrobiopterin (BH4). NOS has recently been shown to be subject to inhibition by its product, NO. Preliminary data by us indicate that a possible role for BH4 is to prevent and/or reverse the NO-mediated inhibition of NOS. The objective of this study was to elucidate the mechanism by which BH4 protects NOS against NO inhibition. Protection of NOS from NO inhibition was observed by both BH4 and the BH4 regeneration system,
dihydropteridine reductase
(
DHPR
)/NADH. NO, rather than an oxidation product, appears to be the inhibitory species. Protection by BH4 is not likely due to a simple chemical reaction between BH4 and NO or its oxidation product, NO2. The results are consistent with a protective mechanism by which BH4 may act as a nonstoichiometric reducing agent for a redox active enzyme component, such as the ironheme, to prevent NO ligation.
...
PMID:The protective effect of tetrahydrobiopterin on the nitric oxide-mediated inhibition of purified nitric oxide synthase. 752
Nitric oxide synthases require a surprisingly rich selection of cofactors to perform the conversion of L-arginine to citrulline and nitric oxide (NO): NADPH,
FAD
, FMN, heme and tetrahydrobiopterin. In a previous minireview in this journal we summarized work concerning the induction of tetrahydrobiopterin biosynthesis by cytokines, which yields increased intracellular tetrahydrobiopterin concentrations supporting NO formation by intact cells (P.S.E.B.M. 203:1-12). The present review updates work on the induction of tetrahydrobiopterin biosynthesis by cytokines, and summarizes recent advances in research of tetrahydrobiopterin dependence of the NO synthase reaction. Studies using recombinant NO synthases and site-directed mutations thereof have localized several amino acids critical for tetrahydrobiopterin binding, which are discussed in reference to the recently published crystal structure of the dimer of the oxygenase domain of murine inducible NO synthase with substrate and pterin. Allosteric actions of tetrahydrobiopterin on NO synthases are stabilization of dimers, stabilization of a conformation with high-spin heme iron, and support of binding of the substrate L-arginine. Since the 4-amino analog of tetrahydrobiopterin, which is a
dihydropteridine reductase
inhibitor, supports these allosteric actions but inhibits the enzyme activity, tetrahydrobiopterin appears to play a redox-active role in stimulating the NO synthase reaction in addition to its allosteric actions on NO synthases. Amelioration of endothelial dysfunction by tetrahydrobiopterin in animal models and in humans in vivo has been observed. It remains to be investigated, however, to what extent the role of tetrahydrobiopterin as cofactor of NO synthases contributes to these in vivo effects of tetrahydrobiopterin.
...
PMID:Tetrahydrobiopterin, cytokines, and nitric oxide synthesis. 982 40